Patents by Inventor Martin Davis
Martin Davis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140370690Abstract: A process is disclosed for producing quantum dots (QDs) by reacting one or more core semiconductor precursors with phosphine in the presence of a molecular cluster compound. The core semiconductor precursor(s) provides elements that are incorporated into the QD core semiconductor material. The core semiconductor also incorporates phosphorus, which is provided by the phosphine. The phosphine may be provided to the reaction as a gas or may, alternatively, be provided as an adduct of another material.Type: ApplicationFiled: March 12, 2014Publication date: December 18, 2014Applicant: Nanoco Technologies, Ltd.Inventors: James Harris, Nigel Pickett, Abdur-Rehman Irshad, Martin Davis, Paul Glarvey, Nathalie Gresty, Heather Yates
-
Publication number: 20140310180Abstract: Providing for a mobile communication device (MCD) credit account and credit transactions by way of such an MCD is described herein. As an example, a credit account sponsored by a financial or commercial entity can be associated with a unique ID of an MCD. The MCD can interface with another electronic device and initiate credit transactions, such as commercial purchases, credit transfers, currency conversions, and the like, via the interface. Further, rules provided by the sponsoring entity can guide such transactions, enforcing credit limits, for instance. A management component can then synchronize transactions conducted by the device with a server of a financial institution over a remote communication interface, such as the Internet or a cellular/mobile communication network. Accordingly, a mobile device can replace a traditional credit card in transacting credit business.Type: ApplicationFiled: June 27, 2014Publication date: October 16, 2014Applicant: WELLS FARGO BANK, N.A.Inventors: Martin Davis, Michael T. Duke
-
Patent number: 8805740Abstract: Providing for a mobile communication device (MCD) credit account and credit transactions by way of such an MCD is described herein. As an example, a credit account sponsored by a financial or commercial entity can be associated with a unique ID of an MCD. The MCD can interface with another electronic device and initiate credit transactions, such as commercial purchases, credit transfers, currency conversions, and the like, via the interface. Further, rules provided by the sponsoring entity can guide such transactions, enforcing credit limits, for instance. A management component can then synchronize transactions conducted by the device with a server of a financial institution over a remote communication interface, such as the Internet or a cellular/mobile communication network. Accordingly, a mobile device can replace a traditional credit card in transacting credit business.Type: GrantFiled: March 27, 2013Date of Patent: August 12, 2014Assignee: Wells Fargo Bank, N.A.Inventors: Martin Davis, Michael Thomas Duke
-
Patent number: 8604051Abstract: Novel processes for the preparation of thieno[2,3-b]pyridine derivatives which are substituted in the 2-position by a substituted anilino moiety and intermediates thereto are provided. The compounds prepared by the present processes may be useful, for example, as selective inhibitors of human MEK (MAPKK) enzymes, and are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, proliferative (including oncological) and nociceptive conditions. The present processes may offer improved yields, chemical or stereochemical purity, ease of preparation and/or isolation of intermediates and final product, and more industrially useful reaction conditions and workability.Type: GrantFiled: February 6, 2013Date of Patent: December 10, 2013Assignee: UCB Pharma S.A.Inventors: Martin Clive Hutchings, Sarah Catherine Archibald, Daniel Christopher Brookings, Jeremy Martin Davis, James Andrew Johnson, Barry John Langham, Judi Charlotte Neuss
-
Publication number: 20130220325Abstract: This invention relates to a treatment device (10) and method of use, and in particular to a treatment device adapted to assist the clearance of bronchial secretions in persons whose cough function is impaired. The invention provides a treatment device having a pump (12) with a negative pressure inlet side (22) and a positive pressure outlet side (24). The device has a breathing tube (14) for connection to a patient, and a pressure sensor (18) adapted to determine the pressure within the breathing tube. A valve (16) selectively connects the breathing tube to the inlet side or the outlet side of the pump whereby to provide cycles of positive and negative pressure within the breathing tube. A controller (26) is provided to control the valve. An indicator (20) alerts the patient to an operational status of the device so that the patient can breathe in time with the device and in particular can seek to cough at the same time as the pressure within the breathing tube is rapidly reduced.Type: ApplicationFiled: September 27, 2011Publication date: August 29, 2013Inventors: Noel Martin Davis, Peter John Bachelor
-
Patent number: 8521856Abstract: In one embodiment, determining a default gateway of a network, determining a MAC address and an IP address associated with the default gateway of the network, updating a table of one or more MAC addresses and corresponding one or more IP addresses based on the detected MAC address and the IP address of the default gateway, detecting in the table of one or more MAC addresses and the corresponding one or more IP addresses, a further MAC address associated with the IP address of the default gateway, determining a port associated with the further MAC address and with the IP address of the default gateway, and disabling the port, are provided.Type: GrantFiled: December 29, 2007Date of Patent: August 27, 2013Assignee: Cisco Technology, Inc.Inventor: Gary Martin Davis
-
Publication number: 20130212016Abstract: Providing for a mobile communication device (MCD) credit account and credit transactions by way of such an MCD is described herein. As an example, a credit account sponsored by a financial or commercial entity can be associated with a unique ID of an MCD. The MCD can interface with another electronic device and initiate credit transactions, such as commercial purchases, credit transfers, currency conversions, and the like, via the interface. Further, rules provided by the sponsoring entity can guide such transactions, enforcing credit limits, for instance. A management component can then synchronize transactions conducted by the device with a server of a financial institution over a remote communication interface, such as the Internet or a cellular/mobile communication network. Accordingly, a mobile device can replace a traditional credit card in transacting credit business.Type: ApplicationFiled: March 27, 2013Publication date: August 15, 2013Applicant: WELLS FARGO, N.A.Inventors: Martin Davis, Michael Thomas Duke
-
Patent number: 8429071Abstract: Providing for a mobile communication device (MCD) credit account and credit transactions by way of such an MCD is described herein. As an example, a credit account sponsored by a financial or commercial entity can be associated with a unique ID of an MCD. The MCD can interface with another electronic device and initiate credit transactions, such as commercial purchases, credit transfers, currency conversions, and the like, via the interface. Further, rules provided by the sponsoring entity can guide such transactions, enforcing credit limits, for instance. A management component can then synchronize transactions conducted by the device with a server of a financial institution over a remote communication interface, such as the Internet or a cellular/mobile communication network. Accordingly, a mobile device can replace a traditional credit card in transacting credit business.Type: GrantFiled: February 15, 2010Date of Patent: April 23, 2013Assignee: Wells Fargo, N.A.Inventors: Martin Davis, Michael Thomas Duke
-
Patent number: 8394822Abstract: A series of thieno[2,3-b]pyridine derivatives which are substituted in the 2-position by a substituted anilino moiety, being selective inhibitors of human MEK (MAPKK) enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, proliferative (including oncological) and nociceptive conditions.Type: GrantFiled: September 5, 2012Date of Patent: March 12, 2013Assignee: UCB Pharma, S.A.Inventors: Martin Clive Hutchings, Sarah Catherine Archibald, Daniel Christopher Brookings, Jeremy Martin Davis, James Andrew Johnson, Barry John Langham, Judi Charlotte Neuss
-
Publication number: 20130030379Abstract: A container for collecting, transporting, storing, delivering and dispensing fluid. The container has a hollow tube with an outer circumference diameter and is configured to receive a plunger. The container also has a circumferential seal assembly secured at one end of the hollow tube. The seal assembly outer diameter is substantially similar to the hollow tube outer diameter.Type: ApplicationFiled: August 31, 2012Publication date: January 31, 2013Applicant: NEOMED, INC.Inventors: Aaron N. INGRAM, Benjamin Martin DAVIS, Anthony C. LAIR, Mark Martin COSTELLO, Tony DOHERTY
-
Publication number: 20120329774Abstract: A series of thieno[2,3-b]pyridine derivatives which are substituted in the 2-position by a substituted anilino moiety, being selective inhibitors of human MEK (MAPKK) enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, proliferative (including oncological) and nociceptive conditions.Type: ApplicationFiled: September 5, 2012Publication date: December 27, 2012Applicant: UCB Pharma S.A.Inventors: Clive Martin Hutchings, Sarah Catherine Archibald, Daniel Christopher Brookings, Jeremy Martin Davis, James Andrew Johnson, Barry John Langham, Judi Charlotte Neuss
-
Patent number: 8283359Abstract: A series of thieno[2,3-b]pyridine derivatives which are substituted in the 2-position by a substituted anilino moiety, being selective inhibitors of human MEK (MAPKK) enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, proliferative (including oncological) and nociceptive conditions.Type: GrantFiled: July 30, 2008Date of Patent: October 9, 2012Assignee: UCB Pharma S.A.Inventors: Martin Clive Hutchings, Sarah Catherine Archibald, Daniel Christopher Brookings, Jeremy Martin Davis, James Andrew Johnson, Barry John Langham, Judi Charlotte Neuss
-
Publication number: 20120234024Abstract: A process and apparatus that includes a cryogenic source for providing a cryogenic fluid for vaporization, a cryogenic pump in fluid flow communication with the cryogenic source for increasing the pressure of the cryogenic fluid, an unfired vaporizer coolant circuit 110 in fluid flow communication with the cryogenic pump and adapted to accept the cryogenic fluid to form a heated stream, a direct-fired vaporizer downstream and in fluid flow communication with the unfired vaporizer coolant circuit 110 and adapted to accept the heated stream from the unfired vaporizer coolant circuit to form a superheated stream; and a diesel engine power unit 118 to provide power to the cryogenic pump, the unfired vaporizer coolant circuit 110, and the direct-fired vaporizer.Type: ApplicationFiled: October 14, 2010Publication date: September 20, 2012Applicant: AIR PRODUCTS AND CHEMICALS, INC.Inventors: John Charles Street, Paul Martin Davis
-
Patent number: 8046264Abstract: A method and system of marketing a consumable may include alerting a customer, via a printer status application, to the status of a consumable in a printing device. A printer identifier may be identified for the printing device via the printer status application. Information about a plurality of product selling entities and associations between each entity and one or more printer identifiers may be maintained in a computer-readable medium. The product selling entity that corresponds to the printer identifier may be determined. The customer may be directed to the product selling entity.Type: GrantFiled: April 30, 2007Date of Patent: October 25, 2011Assignee: Xerox CorporationInventors: Gary Martin Davis, David Rocco Arden Campbell
-
Patent number: 7795256Abstract: A series of thieno[2,3-b]pyridin-6(7H)-one derivatives, substituted in the 3-position by an arylcarbonyl or heteroaryl-carbonyl moiety, being inhibitors of p38 MAP kinase, are accordingly of use in medicine, for example in the treatment and/or prevention of immune or inflammatory disorders.Type: GrantFiled: October 22, 2004Date of Patent: September 14, 2010Assignee: UCB Pharma S.A.Inventors: Rikki Peter Alexander, Jeremy Martin Davis, Martin Clive Hutchings, Victoria Elizabeth Laing, Graham Peter Trevitt
-
Patent number: 7763729Abstract: Bicyclic heteroaromatic derivatives of formula (1) are described: F(1) where: the dashed line joining A and C(Ra) is present and represents a bond and A is a —N? atom or a —C(Rb)? group, or the dashed line is absent and A is a —N(Rb)—, or —C(Rb)(Rc)— group; X is an —O—, —S— or substituted nitrogen atom or a —S(O)—, —S(O2)— or —NH-group; Y is a nitrogen or substituted carbon atom or a —CH? group; n is zero or the integer 1; Alk1 is an optionally substituted aliphatic or heteroaliphatic chain L1 is a covalent bond or a linker atom or group; Cy1 is a hydrogen atom or an optionally substituted cycloaliphatic, polycycloaliphatic, heterocycloaliphatic, polyheterocycloaliphatic, aromatic or heteroaromatic group; Ar is an optionally substituted aromatic or heteroaromatic group; and the remaining substituents are defined in the specification. The compounds are potent and selective inhibitors of p38 kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders.Type: GrantFiled: August 7, 2008Date of Patent: July 27, 2010Assignee: UCB Pharma S.A.Inventors: Daniel Christopher Brookings, Jeremy Martin Davis, Barry John Langham
-
Publication number: 20100179185Abstract: The present invention concerns novel 3-aminothienopyridinone derivatives of the formula I, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.Type: ApplicationFiled: November 23, 2007Publication date: July 15, 2010Applicant: UCB PHARMA, S.A.Inventors: Jeremy Martin Davis, Daniel Christopher Brookings, Barry John Langham, Martin Clive Hutchings
-
Publication number: 20100145835Abstract: Providing for a mobile communication device (MCD) credit account and credit transactions by way of such an MCD is described herein. As an example, a credit account sponsored by a financial or commercial entity can be associated with a unique ID of an MCD. The MCD can interface with another electronic device and initiate credit transactions, such as commercial purchases, credit transfers, currency conversions, and the like, via the interface. Further, rules provided by the sponsoring entity can guide such transactions, enforcing credit limits, for instance. A management component can then synchronize transactions conducted by the device with a server of a financial institution over a remote communication interface, such as the Internet or a cellular/mobile communication network. Accordingly, a mobile device can replace a traditional credit card in transacting credit business.Type: ApplicationFiled: February 15, 2010Publication date: June 10, 2010Applicant: Wells Fargo Bank N.A.Inventors: Martin Davis, Michael Thomas Duke
-
Patent number: 7689508Abstract: Providing for a mobile communication device (MCD) credit account and credit transactions by way of such an MCD is described herein. As an example, a credit account sponsored by a financial or commercial entity can be associated with a unique ID of an MCD. The MCD can interface with another electronic device and initiate credit transactions, such as commercial purchases, credit transfers, currency conversions, and the like, via the interface. Further, rules provided by the sponsoring entity can guide such transactions, enforcing credit limits, for instance. A management component can then synchronize transactions conducted by the device with a server of a financial institution over a remote communication interface, such as the Internet or a cellular/mobile communication network. Accordingly, a mobile device can replace a traditional credit card in transacting credit business.Type: GrantFiled: November 20, 2007Date of Patent: March 30, 2010Assignee: Wells Fargo Bank N.A.Inventors: Martin Davis, Michael Thomas Duke
-
Patent number: D690007Type: GrantFiled: July 26, 2012Date of Patent: September 17, 2013Assignee: Neomed, Inc.Inventors: Aaron N. Ingram, Benjamin Martin Davis